A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
Condition: Seasonal Influenza Interventions: Biological: Quadrivalent influenza vaccine(0.25ml); Biological: Quadrivalent influenza vaccine(0.5ml); Biological: Trivalent influenza vaccine(BV); Biological: Trivalent influenza vaccine(BY) Sponsor: Sinovac Biotech Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials